Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer

Meet the Editorial Board: free to download

Volume:15   Issue: 2
Pp: 87-87

DOI: 10.2174/156800961502150320094324

Involvement of Mesenchymal Stem Cells in Cancer Progression and Metastases

Volume:15   Issue: 2
Pp: 88-98
Astra I. Chang, Aaron H. Schwertschkow, Jan A. Nolta and Jian Wu
DOI: 10.2174/1568009615666150126154151

MYC-Mediated Synthetic Lethality for Treating Tumors

Volume:15   Issue: 2
Pp: 99-115
Xin Li, Xin A. Zhang, Xiaoqing Li, Wei Xie and Shiang Huang
DOI: 10.2174/1568009615666150121162921

Phytochemicals for Breast Cancer Therapy: Current Status and Future Implications

Volume:15   Issue: 2
Pp: 116-135
Jawed A. Siddiqui, Aru Singh, Megha Chagtoo, Nidhi Singh, Madan M. Godbole and Bandana Chakravarti
DOI: 10.2174/1568009615666141229152256

Atypical PKCι as Target for Glioblastoma Therapy

Volume:15   Issue: 2
Pp: 136-144
Ian A.J. Lorimer
DOI: 10.2174/1568009615666150201220250

The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies

Volume:15   Issue: 2
Pp: 145-157
Jinming Shi, Aixin Hao, Qiang Zhang and Guangchao Sui
DOI: 10.2174/1568009615666150131124200

Identification of VEGFR2-Binding Peptides Using High Throughput Bacterial Display Methods and Functional Assessment

Volume:15   Issue: 2
Pp: 158-170
Kefeng Pu, Lihua Yuan, Lisha Chen, Anxin Wang, Xuan Zhou, Hailu Zhang and Yimin Zhu
DOI: 10.2174/156800961502150320112339